Bidding farewell to 2023, the Healthcare Pharmaceuticals Ltd. Lilly Diabetes team ushered in 2024 with a dynamic three-day Annual Business Conference held from February 8-10, 2024, in the beautiful seaside city of Cox's Bazar. The event brought together team members, HPL-Lilly management, and alliance partners from Eli Lilly & Co., uniting them under the theme "One Team, One Vision, One Mission: Be The One."

During the conference, the team reaffirmed their commitment to leading the analogue diabetes market in the upcoming year. The event focused on unveiling and discussing the strategies for 2024, ensuring a clear path forward toward market leadership. The team actively engaged in interactive sessions and workshops, where they collaborated on product learning and exchanged ideas for achieving their collective goals.

A key highlight of the event was the recognition of top achievers, celebrating their remarkable contributions throughout the previous year. The conference was further energized by vibrant performances from team members, adding a colorful and celebratory atmosphere to the gathering.

With the guidance from HPL-Lilly management and support from Eli Lilly & Co., the Healthcare Lilly Diabetes team is poised to continue their journey toward becoming the number one leader in the market.